Schizophrenic sympyoms-related disturbance of cerebral neurotransmission
Schizophrenic sympyoms-related disturbance of cerebral neurotransmission
批准号:
04670718
负责人:
NISHIKAWA Toru
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In order to get an insight into the possible dysregulation of cerebral neurotransmission and neural networks in schizophrenic disorders, we investigated the effects of schizophrenomimetic drugs including methamphetamine (MAP), cocaine and phencyclidine (PCP) on c-fos gene expression and dopamine (DA) metabolism in rat brain. Since D-serine, which has recently been shown to be an endogenous amino acid, antagonizes the psychotomimetic action of PCP and MAP in the rat, the anatomical distribution of the D-amino acid was examined in rat, mouse and human tissues.Acute administration of MAP caused a widespread induction of nuclear c-Fos protein-like immunoreactivity in rat brain at 56-80 postnatal days. The greatest density of c-Fos positive cells was found in the pyriform cortex and olfactory tubercle followed by the II-VI layrs of the neocortex, septum, striatum, etc.In 8-day-old neonatal rats, acute MAP injection failed to cause c-fos expression in the II-V layrs of the neocortex, but ind … More uced the proto-oncogene product in a deeper part of the layr VI of the neocortex, the paleocortex including the pyriform and the subcortical areas. MAP-induced c-Fos positive cells in the neocortex increased in number and distribution with postnatal development and showed the adult pattern after 21-23 postnatal days. In agreement with the results of immunohistochemical studies, Northen blot analysis revealed that, in the neocortex, a marked c-fos induction was observed after MAP injection at 21, 23, 25, 30 and 49 days postpartum, whereas the MAP treatment caused a low expression of the immediate early gene at 8 and 14 postnatal days. These distinct patterns of c-fos expression in the neocortical areas might reflect differences in responsive neuronal circuits to the drugs at the neonatal and young adult periods, because the effects of pharmacological, electrical and physiological stimuli have been considered to be traced by the prote-oncogene expression in the nervous system. Together with the observation that stimulant-induced sensitization occurs sometime after the third week of postnatal life, the present results, therefore, suggest that the maturation of certain neuronal circuits in the neocortex might be needed to develop behavioral sensitization to MAP and cocaine.At 8 and 56 postnatal days, the distibution patterns of c-Fos positive cells after MAP were similar to those after DA agonists, cocaine and apomorphine, but clearly distinct from those after PCP and dizocilpine which are NMDA antagonists. Moreover, MAP markedly augmented extracellular DA release in the frontal cortex and striatum in a tetrodotoxin-insensitive manner in adult rats while PCP produced a frontal cortex-preferring and tetrodotoxin-sensitive increase in DA liberation. The differential effects of MAP and PCP could, in part, explain the differences between PCP-and MAP-induced psychosis.An endogenous anti-PCP and-MAP substance D-serine was found to exclusively occur in brains with a persistent high content throughout life in the rat, mouse and human. The patterns of the regional variations in brain D-serine were closely correlated with those of the NMDA type glutamate receptor. Together with a selective stimuditribution of the NMDA-related glycine site by D-serine, these data suggest that the D-amino acid is a novel canditate as an intrinsic ligand for the glycine modulatory aite of the NMDA receptor and might be involved in pathophysiology of certain neuropsychiatric disorders including a subtype of schizophrenia. Less
期刊论文(102)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
T.Nishikawa,et al.: "Disturbed neurotransmission via the N-methyl-D-aspartate receptor and schizophrenia" In The biology of schizophrenia(eds.T.Moroji and K.Yamamoto)Elsevier(In press.), (1994)
T.Nishikawa 等人:“通过 N-甲基-D-天冬氨酸受体干扰神经传递和精神分裂症”,《精神分裂症生物学》(编辑 T.Moroji 和 K.Yamamoto)爱思唯尔(出版中),(1994 年)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Shirayama, T.Nishikawa, K.Takahashi.: "Defferential effects of repeated dl-pentazocine treatment on sigma binding sites in discrete brain areas of the rat." Neurosci.Lett.165. 219-222 (1994)
Y.Shirayama、T.Nishikawa、K.Takahashi.:“重复 dl-喷他佐辛治疗对大鼠离散脑区 sigma 结合位点的不同影响。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A.Hashimoto,et al: "Free D-serine,D-aspartate and D-alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase." Neuroscience letters. 152. 33-36 (1993)
A.Hashimoto 等人:“缺乏 D-氨基酸氧化酶的突变小鼠的中枢神经系统和血清中存在游离的 D-丝氨酸、D-天冬氨酸和 D-丙氨酸。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y.Shirayama,et al: "Differential effects of repeated dl-pentazocine treatment on sigma binding sites in discrete brain areas of the rat." Neuroscience Lett.,. 165. 219-222 (1994)
Y.Shirayama 等人:“重复 dl-喷他佐辛治疗对大鼠离散脑区 sigma 结合位点的不同影响。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
西川 徹: "グルタミン酸と精神疾患" ブレインサイエンス. 4. 187-198 (1993)
Toru Nishikawa:“谷氨酸和精神疾病”《脑科学》4. 187-198 (1993)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 41 条
Studies on the development of novel pharmacotherapy for schizophrenia that regulates the glutamate receptors
-
批准号:21390330
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2009
-
负责人:NISHIKAWA Toru
-
依托单位:
Studies on the development of glutamate system-targeted novel pharmacotherapy for schizophrenia
-
批准号:19390302
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2007
-
负责人:NISHIKAWA Toru
-
依托单位:
Elucidation of molecular pathomechanisms of schizophrenia
-
批准号:17025016
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$68.22万
-
财政年份:2005
-
负责人:NISHIKAWA Toru
-
依托单位:
A neurodevelopmental pharmacological approach to the molecular pathophysiology of schizophrenic symptoms
-
批准号:14207040
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$32.2万
-
财政年份:2002
-
负责人:NISHIKAWA Toru
-
依托单位:
A pharmacological approach to the molecular basis of disturbed brain information processing of schizophrenia
-
批准号:12470192
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.5万
-
财政年份:2000
-
负责人:NISHIKAWA Toru
-
依托单位:
精神分裂病における神経情報処理障害の原因となる遺伝子異常の探索
-
批准号:10670929
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1998
-
负责人:NISHIKAWA Toru
-
依托单位:
Molecular mechanisms of schizophrenic symptoms
-
批准号:08671124
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1996
-
负责人:NISHIKAWA Toru
-
依托单位:
Metabolism and Physiological functions of endogenous D-serine
-
批准号:07557242
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$3.01万
-
财政年份:1995
-
负责人:NISHIKAWA Toru
-
依托单位:
Molecular pharmacological approach to the disturbances of brain neuron circuits involved in schizophrenia
-
批准号:06670993
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:NISHIKAWA Toru
-
依托单位:
Behavioral and biochemical effects of schizophrenomimetic drugs, phencyclidine and methamphetamine, in the rat
-
批准号:02670527
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1990
-
负责人:NISHIKAWA Toru
-
依托单位:
海外基金